BNP Paribas Diversipierre: Temporary suspension of subscription fees from 15 July 2024
2024-07-15
Press releases

BNP Paribas Diversipierre is currently redefining its strategy and preparing to build a portfolio in line with the new market conditions. In this context, BNP Paribas REIM has decided to temporarily suspend the subscription fees paid to the fund.
BNP Paribas Diversipierre: Temporary suspension of subscription fees from 15 July 2024
Principle
The subscription fee paid to the fund is intended to cover the costs incurred during the acquisition of the properties by the OPCI.
The goal is for each investor to fairly contribute to these acquisition costs.
This fee is deducted at the time of subscription as a fixed percentage of the invested amount: the investors thus finance their share of acquisition costs in a single payment, avoiding any future negative impact on performance.
Changes effective from 15 July 2024
The rate of the rights paid to the fund, which was previously 3.50%, will be temporarily reduced to 0% from 15 July 2024, onwards.
Subscription Fees before 15 July 2024: 3.50%
Subscription Fees from 15 July 2024, onwards: 0%
Example: For an investment of €100 under normal pricing conditions, the effective investment would have been €96.50. Now, the entire amount will be invested in the OPCI, i.e. €100.
New Subscriptions: This temporary reduction provides a low-cost investment opportunity for new subscribers.
Current Client Portfolio: This measure does not affect previously subscribed shares.
Period: The management company reserves the right to reapply subscription fees at any time via a dedicated message on the BNP Paribas REIM France website.
Disclaimer:
Investing in the products mentioned in this publication involves risks, including that of capital loss. Potential earnings may vary upwards or downwards and are not guaranteed. The amount that is reasonable to invest in these products depends on your personal wealth, your investment horizon and your appetite for the risks specific to a real estate investment.
For more details regarding the risks, please refer to the regulatory documentation of the products available on our website.